Compare MO & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MO | MDT |
|---|---|---|
| Founded | 1822 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.6B | 114.9B |
| IPO Year | N/A | N/A |
| Metric | MO | MDT |
|---|---|---|
| Price | $58.55 | $98.67 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 18 |
| Target Price | $60.29 | ★ $108.44 |
| AVG Volume (30 Days) | ★ 9.4M | 6.9M |
| Earning Date | 01-29-2026 | 11-18-2025 |
| Dividend Yield | ★ 7.30% | 2.88% |
| EPS Growth | N/A | ★ 12.98 |
| EPS | ★ 5.24 | 3.69 |
| Revenue | $20,166,000,000.00 | ★ $34,758,000,000.00 |
| Revenue This Year | $1.45 | $8.60 |
| Revenue Next Year | N/A | $5.83 |
| P/E Ratio | ★ $11.08 | $26.73 |
| Revenue Growth | N/A | ★ 5.34 |
| 52 Week Low | $50.08 | $79.29 |
| 52 Week High | $68.60 | $106.33 |
| Indicator | MO | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 43.54 | 47.56 |
| Support Level | $58.22 | $97.17 |
| Resistance Level | $59.75 | $99.26 |
| Average True Range (ATR) | 0.75 | 1.45 |
| MACD | 0.14 | -0.64 |
| Stochastic Oscillator | 33.26 | 23.81 |
Altria comprises Philip Morris USA, US Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the US with 42% annual share in 2024. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev and a 41% stake in cannabis manufacturer Cronos. It also acquired vaping company Njoy Holdings in 2023 and operates a joint venture with Japan Tobacco in the heated tobacco category for the US.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.